Research study Program year 2023 Source: CMS Open Payments

MRD PoCP study in NFLD 12 wks

Research payments

$1,014,015

28 payments

Through program year 2023, $1,014,015 in research payments was reported against MRD PoCP study in NFLD 12 wks, across 28 payments, paid by Boehringer Ingelheim International GmbH.

Paid by: Boehringer Ingelheim International GmbH
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2023	Research	$1,014,015	28

Breakdown

Who paid Research payments · program year 2023

Boehringer Ingelheim International GmbH $1,014,015 28 payments

Who received the money Research payments · program year 2023

Catalina Research Institute LLC Organisation paid for research $518,917 2 payments
Texas Liver Institute Organisation paid for research $182,674 2 payments
Floridian Clinical Research Organisation paid for research $92,193 2 payments
Wake Research Associates Organisation paid for research $47,366 4 payments
Research Centers Of America Organisation paid for research $23,087 2 payments
Advanced Clinical Research Inc Organisation paid for research $22,985 2 payments
Accel Research Sites Deland Organisation paid for research $22,685 2 payments
Velocity Clinical Research-Chula Vista Organisation paid for research $20,526 2 payments
Velocity Clinical Research San Diego Organisation paid for research $20,491 2 payments
Centricity Research Organisation paid for research $19,051 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.